|
ENST00000584923.1
|
ENST00000584923.1_153_216_+ |
153–216 |
117.00 |
1.99 |
0.34 |
100.0 |
SNORD3A-201
|
snoRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000585078.1
|
ENST00000585078.1_1_83_+ |
1–83 |
5600.00 |
76.53 |
16.34 |
100.0 |
SNORD92-201
|
snoRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000585881.5
|
ENST00000585881.5_140_162_+ |
140–162 |
3116.00 |
40.07 |
9.09 |
100.0 |
NSRP1-214
|
protein coding
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000585881.5
|
ENST00000585881.5_104_126_+ |
104–126 |
3503.00 |
45.05 |
10.22 |
87.18 |
NSRP1-214
|
protein coding
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000587762.2
|
ENST00000587762.2_6337_6420_+ |
6337–6420 |
1237.00 |
15.22 |
3.61 |
100.0 |
MIR23AHG-201
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000587762.2
|
ENST00000587762.2_6314_6334_+ |
6314–6334 |
2951.00 |
36.30 |
8.61 |
95.63 |
MIR23AHG-201
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000587762.2
|
ENST00000587762.2_6462_6481_+ |
6462–6481 |
460.00 |
5.66 |
1.34 |
90.2 |
MIR23AHG-201
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000587762.2
|
ENST00000587762.2_6619_6638_+ |
6619–6638 |
1231.00 |
15.14 |
3.59 |
91.39 |
MIR23AHG-201
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000587762.2
|
ENST00000587762.2_6619_6641_+ |
6619–6641 |
615.00 |
7.56 |
1.79 |
76.78 |
MIR23AHG-201
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000591345.5
|
ENST00000591345.5_1414_1429_+ |
1414–1429 |
1641.00 |
68.83 |
4.79 |
100.0 |
ODAD3-204
|
nonsense mediated decay
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000592790.1
|
ENST00000592790.1_3381_3401_+ |
3381–3401 |
338.00 |
2.24 |
0.99 |
100.0 |
VMP1-217
|
retained intron
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000592790.1
|
ENST00000592790.1_3343_3402_+ |
3343–3402 |
174.00 |
1.15 |
0.51 |
100.0 |
VMP1-217
|
retained intron
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000592790.1
|
ENST00000592790.1_3343_3366_+ |
3343–3366 |
8589.00 |
56.83 |
25.05 |
64.07 |
VMP1-217
|
retained intron
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000595794.5
|
ENST00000595794.5_236_279_+ |
236–279 |
363.00 |
0.07 |
1.06 |
100.0 |
C19orf48P-203
|
retained intron
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000595794.5
|
ENST00000595794.5_236_318_+ |
236–318 |
375848.75 |
68.18 |
1096.35 |
73.99 |
C19orf48P-203
|
retained intron
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000595794.5
|
ENST00000595794.5_236_320_+ |
236–320 |
141549.69 |
25.68 |
412.90 |
27.09 |
C19orf48P-203
|
retained intron
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000595794.5
|
ENST00000595794.5_236_330_+ |
236–330 |
5584.00 |
1.01 |
16.29 |
89.23 |
C19orf48P-203
|
retained intron
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000595794.5
|
ENST00000595794.5_236_276_+ |
236–276 |
61.00 |
0.01 |
0.18 |
100.0 |
C19orf48P-203
|
retained intron
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000595794.5
|
ENST00000595794.5_230_318_+ |
230–318 |
5.00 |
0.00 |
0.01 |
100.0 |
C19orf48P-203
|
retained intron
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000600027.5
|
ENST00000600027.5_434_519_+ |
434–519 |
1065.00 |
32.13 |
3.11 |
100.0 |
RPS11-206
|
retained intron
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000600027.5
|
ENST00000600027.5_441_519_+ |
441–519 |
1400.00 |
42.23 |
4.08 |
100.0 |
RPS11-206
|
retained intron
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000602315.3
|
ENST00000602315.3_752_771_+ |
752–771 |
129373.00 |
83.49 |
377.38 |
84.9 |
CARMN-209
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000602478.2
|
ENST00000602478.2_671_758_+ |
671–758 |
670.00 |
26.22 |
1.95 |
100.0 |
ENST00000602478
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000604535.1
|
ENST00000604535.1_1396_1410_+ |
1396–1410 |
131.00 |
56.71 |
0.38 |
100.0 |
PPFIA1P1-201
|
processed pseudogene
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000606412.1
|
ENST00000606412.1_4_67_+ |
4–67 |
1415.00 |
38.52 |
4.13 |
100.0 |
SNORD114-21-201
|
snoRNA
|
subcutaneous adipose tissue
(Tissue)
|